Literature DB >> 26404991

Dentists, antibiotics and Clostridium difficile-associated disease.

N Beacher1, M P Sweeney1, J Bagg1.   

Abstract

Dentists prescribe significant volumes of antimicrobial drugs within primary care settings. There is good evidence that many of the prescriptions are not justified by current clinical guidance and that that there is considerable misuse of these drugs in dentistry. One of the risks associated with antibiotic administration is Clostridium difficile-associated disease (CDAD), an entity of which many healthcare workers, including dentists, have little knowledge or understanding. This review seeks to identify the extent and nature of the problem and provides an up to date summary of current views on CDAD, with particular reference to community acquired disease. As for all healthcare workers, scrupulous attention to standard infection control procedures and reducing inappropriate antibiotic prescribing are essential to reduce the risks of CDAD, prevent emergence of further resistant strains of microorganisms and maintain the value of the arsenal of antibiotics currently available to us.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26404991     DOI: 10.1038/sj.bdj.2015.720

Source DB:  PubMed          Journal:  Br Dent J        ISSN: 0007-0610            Impact factor:   1.626


  88 in total

Review 1.  Clindamycin and dentistry.

Authors:  L D Addy; M V Martin
Journal:  Br Dent J       Date:  2005-07-09       Impact factor: 1.626

2.  The impact of clinical audit on antibiotic prescribing in general dental practice.

Authors:  R A C Chate; S White; L R O Hale; A P Howat; J Bottomley; J Barnet-Lamb; J Lindsay; T I Davies; J M Heath
Journal:  Br Dent J       Date:  2006-11-25       Impact factor: 1.626

3.  Characterization of antibiotic resistance determinants in oral biofilms.

Authors:  Seon-Mi Kim; Hyeong C Kim; Seok-Woo S Lee
Journal:  J Microbiol       Date:  2011-09-02       Impact factor: 3.422

Review 4.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

Review 5.  Amoxicillin and amoxicillin plus clavulanate: a safety review.

Authors:  Francesco Salvo; Angelina De Sarro; Achille Patrizio Caputi; Giovanni Polimeni
Journal:  Expert Opin Drug Saf       Date:  2009-01       Impact factor: 4.250

6.  Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.

Authors:  E J Kuijper; F Barbut; J S Brazier; N Kleinkauf; T Eckmanns; M L Lambert; D Drudy; F Fitzpatrick; C Wiuff; D J Brown; J E Coia; H Pituch; P Reichert; J Even; J Mossong; A F Widmer; K E Olsen; F Allerberger; D W Notermans; M Delmée; B Coignard; M Wilcox; B Patel; R Frei; E Nagy; E Bouza; M Marin; T Akerlund; A Virolainen-Julkunen; O Lyytikäinen; S Kotila; A Ingebretsen; B Smyth; P Rooney; I R Poxton; D L Monnet
Journal:  Euro Surveill       Date:  2008-07-31

7.  Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis.

Authors:  K H Kim; R Fekety; D H Batts; D Brown; M Cudmore; J Silva; D Waters
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

Review 8.  Clostridium difficile: epidemiology, diagnostic and therapeutic possibilities-a systematic review.

Authors:  M Kazanowski; S Smolarek; F Kinnarney; Z Grzebieniak
Journal:  Tech Coloproctol       Date:  2013-11-01       Impact factor: 3.781

9.  Dental care resistance prevention and antibiotic prescribing modification-the cluster-randomised controlled DREAM trial.

Authors:  Christin Löffler; Femke Böhmer; Anne Hornung; Hermann Lang; Ulrike Burmeister; Andreas Podbielski; Anja Wollny; Günther Kundt; Attila Altiner
Journal:  Implement Sci       Date:  2014-02-22       Impact factor: 7.327

10.  Feasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.

Authors:  Johannes P Borde; Klaus Kaier; Michaela Steib-Bauert; Werner Vach; Annette Geibel-Zehender; Hansjörg Busch; Hartmut Bertz; Martin Hug; Katja de With; Winfried V Kern
Journal:  BMC Infect Dis       Date:  2014-04-15       Impact factor: 3.090

View more
  7 in total

1.  Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts.

Authors:  C Pankhurst; R Rautemaa-Richardson; N Seoudi; A Smith; M Wilson
Journal:  Br Dent J       Date:  2016-01-15       Impact factor: 1.626

2.  Prescribing: Congratulations.

Authors:  M Thornhill; M Dayer; B Prendergast; L Baddour; S Jones; P Lockhart
Journal:  Br Dent J       Date:  2015-12       Impact factor: 1.626

3.  Antibiotic use for irreversible pulpitis.

Authors:  Anirudha Agnihotry; Wendy Thompson; Zbys Fedorowicz; Esther J van Zuuren; Julie Sprakel
Journal:  Cochrane Database Syst Rev       Date:  2019-05-30

4.  Antibiotic prescribing by general dentists in the United States, 2013.

Authors:  Rebecca M Roberts; Monina Bartoces; Sydney E Thompson; Lauri A Hicks
Journal:  J Am Dent Assoc       Date:  2017-01-23       Impact factor: 3.634

5.  Antimicrobial prescribing by dentists in Wales, UK: findings of the first cycle of a clinical audit.

Authors:  A L Cope; E Barnes; E P Howells; A M Rockey; A J Karki; M J Wilson; M A O Lewis; J G Cowpe
Journal:  Br Dent J       Date:  2016-07-08       Impact factor: 1.626

6.  Oral antibiotic prescribing by NHS dentists in England 2010-2017.

Authors:  Martin H Thornhill; Mark J Dayer; Michael J Durkin; Peter B Lockhart; Larry M Baddour
Journal:  Br Dent J       Date:  2019-12       Impact factor: 1.626

7.  Enhanced efficacy of chemically modified curcumin in experimental periodontitis: systemic implications.

Authors:  Howard H Wang; Hsi-Ming Lee; Veena Raja; Wei Hou; Vincent J Iacono; Joseph Scaduto; Francis Johnson; Lorne M Golub; Ying Gu
Journal:  J Exp Pharmacol       Date:  2019-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.